UPDATE 1-Abbott tops profit estimates on strong medical device sales

Oct 18 (Reuters) - Diversified healthcare company Abbott Laboratories' profit beat analysts' estimates, driven by strong sales in its medical devices business.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.